Most people are probably now aware that a person’s biological sex does not automatically correspond to their social gender. Gender-appropriate alternatives in language, for example, now ensure that no gender is excluded. However, what is the significance of the debates about sex and gender for research? 

Professor Dr med. Sabine Oertelt-Prigione heads the Gender Medicine Department at the Radboud University in Nijmegen in the Netherlands and will report on her research work into elements such as the effect of sex and gender on biomedical research and why biological and social sexes/genders should be taken into consideration; this will take place as a guest lecture at the Frankfurt Cancer Institute (FCI) LOEWE Centre at 2:30 p.m. on 27 April 2021. “Does the sex of a cell affect the experimental results?” “Does the gender of the scientist conducting the research have an effect on the research being conducted?” or “Does a person’s gender really affect the results of the treatment?” These are just some of the questions that Oertelt-Prigione will touch on during her lecture. She will also bring with her practical examples from various disciplines and different fields of research.

The professor would also like to discuss corrective measures and best-practice approaches. How can sex- and gender-sensitive projects be organised and which factors need to be taken into consideration when doing so?

There will be an opportunity to become involved in interactive discussions after the lecture in English. Please contact the FCI coordinator, Sandra Schmitz, at schmitz@fci.health to register and receive the access data for the virtual event.